Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries

Key messages from Disease Control Priorities, 3rd edition

Disease Control Priorities-3 Cancer Author Group

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.

Original languageEnglish (US)
Pages (from-to)2133-2144
Number of pages12
JournalThe Lancet
Volume387
Issue number10033
DOIs
StatePublished - May 21 2016

Fingerprint

Costs and Cost Analysis
Neoplasms
Palliative Care
Uterine Cervical Neoplasms
Premature Mortality
Liver Neoplasms
Opioid Analgesics
Tobacco
Therapeutics
Breast Neoplasms
Viruses
Health

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries : Key messages from Disease Control Priorities, 3rd edition. / Disease Control Priorities-3 Cancer Author Group.

In: The Lancet, Vol. 387, No. 10033, 21.05.2016, p. 2133-2144.

Research output: Contribution to journalReview article

@article{455244d05c964460812cfb02cedb0081,
title = "Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: Key messages from Disease Control Priorities, 3rd edition",
abstract = "Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3{\%} of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.",
author = "{Disease Control Priorities-3 Cancer Author Group} and Hellen Gelband and Rengaswamy Sankaranarayanan and Gauvreau, {Cindy L.} and Susan Horton and Anderson, {Benjamin O.} and Freddie Bray and James Cleary and Dare, {Anna J.} and Lynette Denny and Gospodarowicz, {Mary K.} and Sumit Gupta and Howard, {Scott C.} and Scott Howard and Felicia Knaul and Carol Levin and Linda Rabeneck and Preetha Rajaraman and Terrence Sullivan and Trimble, {Edward L.} and Prabhat Jha",
year = "2016",
month = "5",
day = "21",
doi = "10.1016/S0140-6736(15)00755-2",
language = "English (US)",
volume = "387",
pages = "2133--2144",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10033",

}

TY - JOUR

T1 - Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries

T2 - Key messages from Disease Control Priorities, 3rd edition

AU - Disease Control Priorities-3 Cancer Author Group

AU - Gelband, Hellen

AU - Sankaranarayanan, Rengaswamy

AU - Gauvreau, Cindy L.

AU - Horton, Susan

AU - Anderson, Benjamin O.

AU - Bray, Freddie

AU - Cleary, James

AU - Dare, Anna J.

AU - Denny, Lynette

AU - Gospodarowicz, Mary K.

AU - Gupta, Sumit

AU - Howard, Scott C.

AU - Howard, Scott

AU - Knaul, Felicia

AU - Levin, Carol

AU - Rabeneck, Linda

AU - Rajaraman, Preetha

AU - Sullivan, Terrence

AU - Trimble, Edward L.

AU - Jha, Prabhat

PY - 2016/5/21

Y1 - 2016/5/21

N2 - Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.

AB - Investments in cancer control - prevention, detection, diagnosis, surgery, other treatment, and palliative care - are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.

UR - http://www.scopus.com/inward/record.url?scp=84949024349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949024349&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(15)00755-2

DO - 10.1016/S0140-6736(15)00755-2

M3 - Review article

VL - 387

SP - 2133

EP - 2144

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10033

ER -